A new study tested risankizumab, approved for the treatment of psoriasis, in patients with severe asthma and found it worsened their asthma symptoms.
top of page
bottom of page
A new study tested risankizumab, approved for the treatment of psoriasis, in patients with severe asthma and found it worsened their asthma symptoms.
Comments